N-Formyl-L-histidine,
15191-21-6,
L-Histidine, N-formyl-,
(S)-2-Formamido-3-(1H-imidazol-4-yl)propanoic acid,
formylhistidine,
NSC-334340,
N-Formylhistidine #,
AC1MMYWK,
NCIStruc1_000292,
NCIStruc2_000029,
SCHEMBL61920,
CHEMBL1741817,
CTK0H7159,
WFQVSLVQIFFQQN-LURJTMIESA-N,
KS-000013TN,
ANW-21376,
CCG-38324,
MFCD00059159,
NCGC00014776,
NCI334340,
ZINC35024675,
AKOS010366495,
NCGC00014776-02,
NCGC00097877-01,
BBV-32488843,
AX8144399,
TC-110121,
F0133,
FT-0657203,
(2S)-2-formamido-3-(1H-imidazol-5-yl)propanoic acid,
(2S)-3-(1H-imidazol-4-yl)-2-formamidopropanoic acid,
(2S)-2-(Formylamino)-3-(1H-imidazol-4-yl)propanoic acid AldrichCPR,
(2S)-2-(Formylamino)-3-(1H-imidazol-4-yl)propanoic acid, AldrichCPR,
N-Formylhistidine,
C7H9N3O3,
C7-H9-N3-O3,
EINECS 239-248-1,
NSC334340,
CID3246645,